Tune in to @WCVB tonight at 5 p.m. ET, where @EmilyWCVB interviews Intellia President and CEO John Leonard, M.D., about the potential of #CRISPR/Cas9 and #genomeediting to treat rare, genetic diseases: https://t.co/tjsgXkY5NM